Catherine Ramsey Schulte
Stock Analyst at Robert W. Baird
(4.46)
# 1,088
Out of 4,345 analysts
579
Total ratings
49%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Catherine Ramsey Schulte
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintained: Buy | $155 → $156 | $115.84 | +34.67% | 44 | May 26, 2026 | |
| MTD Mettler-Toledo International | Maintained: Hold | $1,445 → $1,194 | $1,093.84 | +9.16% | 28 | May 11, 2026 | |
| NTRA Natera | Maintained: Buy | $257 → $265 | $203.11 | +30.47% | 41 | May 8, 2026 | |
| GH Guardant Health | Maintained: Buy | $120 → $129 | $127.51 | +1.17% | 2 | May 8, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | $28 → $22 | $15.38 | +43.04% | 3 | May 8, 2026 | |
| TECH Bio-Techne | Maintained: Hold | $70 → $49 | $48.09 | +1.89% | 42 | May 7, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $44 → $43 | $21.26 | +102.26% | 46 | May 7, 2026 | |
| WAT Waters | Maintained: Buy | $363 → $387 | $342.18 | +13.10% | 44 | May 6, 2026 | |
| GRAL GRAIL | Maintained: Buy | $82 → $70 | $71.42 | -1.99% | 2 | May 6, 2026 | |
| TEM Tempus AI | Maintained: Buy | $68 → $59 | $47.17 | +25.08% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $65 | $64.17 | +1.29% | 46 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $129 → $125 | $96.79 | +29.15% | 43 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $53 → $43 | $36.13 | +19.01% | 14 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $653 → $639 | $456.21 | +40.07% | 56 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $249 → $245 | $173.13 | +41.51% | 30 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $3 | $4.37 | -31.35% | 23 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $11 | $8.40 | +30.95% | 28 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $109 → $137 | $150.17 | -8.77% | 54 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.12 | n/a | 10 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 8 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $102 | $92.07 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $2.82 | n/a | 11 | Nov 2, 2018 |
Agilent Technologies
May 26, 2026
Maintained: Buy
Price Target: $155 → $156
Current: $115.84
Upside: +34.67%
Mettler-Toledo International
May 11, 2026
Maintained: Hold
Price Target: $1,445 → $1,194
Current: $1,093.84
Upside: +9.16%
Natera
May 8, 2026
Maintained: Buy
Price Target: $257 → $265
Current: $203.11
Upside: +30.47%
Guardant Health
May 8, 2026
Maintained: Buy
Price Target: $120 → $129
Current: $127.51
Upside: +1.17%
Caris Life Sciences
May 8, 2026
Maintained: Buy
Price Target: $28 → $22
Current: $15.38
Upside: +43.04%
Bio-Techne
May 7, 2026
Maintained: Hold
Price Target: $70 → $49
Current: $48.09
Upside: +1.89%
Castle Biosciences
May 7, 2026
Maintained: Buy
Price Target: $44 → $43
Current: $21.26
Upside: +102.26%
Waters
May 6, 2026
Maintained: Buy
Price Target: $363 → $387
Current: $342.18
Upside: +13.10%
GRAIL
May 6, 2026
Maintained: Buy
Price Target: $82 → $70
Current: $71.42
Upside: -1.99%
Tempus AI
May 6, 2026
Maintained: Buy
Price Target: $68 → $59
Current: $47.17
Upside: +25.08%
May 5, 2026
Maintained: Buy
Price Target: $50 → $65
Current: $64.17
Upside: +1.29%
May 4, 2026
Maintained: Buy
Price Target: $129 → $125
Current: $96.79
Upside: +29.15%
Apr 29, 2026
Upgraded: Buy
Price Target: $53 → $43
Current: $36.13
Upside: +19.01%
Apr 24, 2026
Maintained: Buy
Price Target: $653 → $639
Current: $456.21
Upside: +40.07%
Apr 22, 2026
Maintained: Buy
Price Target: $249 → $245
Current: $173.13
Upside: +41.51%
Feb 26, 2026
Maintained: Hold
Price Target: $2 → $3
Current: $4.37
Upside: -31.35%
Feb 12, 2026
Maintained: Buy
Price Target: $17 → $11
Current: $8.40
Upside: +30.95%
Feb 6, 2026
Maintained: Hold
Price Target: $109 → $137
Current: $150.17
Upside: -8.77%
Apr 18, 2022
Rated: Hold
Price Target: n/a
Current: $0.12
Upside: n/a
Apr 18, 2022
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Mar 4, 2019
Maintained: Buy
Price Target: $102
Current: $92.07
Upside: n/a
Nov 2, 2018
Maintained: Buy
Price Target: $9 → $8
Current: $2.82
Upside: n/a